🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 13 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/01/1994 | 46,79 | 47,72 | 45,85 | 45,85 | -2,00% | 4,00% | 8.362 |
| 20/01/1994 | 47,26 | 47,72 | 45,85 | 46,79 | -1,96% | 3,96% | 13.786 |
| 19/01/1994 | 47,72 | 47,72 | 45,85 | 47,72 | +4,08% | 3,92% | 15.923 |
| 18/01/1994 | 47,72 | 47,72 | 45,85 | 45,85 | -2,00% | 3,92% | 11.034 |
| 17/01/1994 | 45,85 | 47,72 | 45,85 | 46,79 | -1,96% | 4,08% | 7.801 |
| 14/01/1994 | 50,53 | 50,53 | 44,92 | 47,72 | +0,00% | 11,11% | 6.572 |
| 13/01/1994 | 47,72 | 50,53 | 47,72 | 47,72 | +0,00% | 5,88% | 1.870 |
| 12/01/1994 | 50,53 | 50,53 | 47,72 | 47,72 | -5,56% | 5,56% | 3.820 |
| 11/01/1994 | 54,27 | 54,27 | 47,72 | 50,53 | -5,26% | 12,07% | 7.320 |
| 10/01/1994 | 50,53 | 53,34 | 48,66 | 53,34 | +11,76% | 9,26% | 5.130 |
| 07/01/1994 | 46,79 | 51,47 | 45,85 | 47,72 | +2,00% | 12,00% | 11.194 |
| 06/01/1994 | 46,79 | 46,79 | 46,79 | 46,79 | +0,00% | 0,00% | 267 |
| 05/01/1994 | 43,98 | 46,79 | 43,98 | 46,79 | +4,17% | 6,38% | 1.202 |
| 04/01/1994 | 43,04 | 45,85 | 43,04 | 44,92 | +0,00% | 6,52% | 3.259 |
| 03/01/1994 | 43,98 | 44,92 | 41,17 | 44,92 | +2,13% | 8,51% | 1.336 |
| 31/12/1993 | 41,17 | 43,98 | 41,17 | 43,98 | +0,00% | 6,82% | 962 |
| 30/12/1993 | 43,98 | 43,98 | 41,17 | 43,98 | +0,00% | 6,38% | 908 |
| 29/12/1993 | 42,58 | 43,98 | 41,17 | 43,98 | +3,30% | 6,59% | 15.309 |
| 28/12/1993 | 42,58 | 42,58 | 42,58 | 42,58 | -1,09% | 0,00% | 187 |
| 27/12/1993 | 44,92 | 44,92 | 43,04 | 43,04 | +0,00% | 4,17% | 5.664 |
| 23/12/1993 | 43,04 | 43,04 | 43,04 | 43,04 | +0,00% | 0,00% | 935 |
| 22/12/1993 | 43,04 | 43,04 | 43,04 | 43,04 | +0,00% | 0,00% | 1.870 |
| 21/12/1993 | 43,04 | 43,98 | 43,04 | 43,04 | +0,00% | 2,17% | 6.145 |
| 20/12/1993 | 44,92 | 44,92 | 43,04 | 43,04 | +0,00% | 4,17% | 721 |
| 17/12/1993 | 43,51 | 43,98 | 43,04 | 43,04 | +0,00% | 2,15% | 17.099 |
| 16/12/1993 | 43,04 | 43,04 | 43,04 | 43,04 | +0,00% | 0,00% | 401 |
| 15/12/1993 | 43,04 | 44,92 | 43,04 | 43,04 | +0,00% | 4,35% | 427 |
| 14/12/1993 | 43,04 | 44,92 | 43,04 | 43,04 | -6,12% | 4,35% | 5.290 |
| 13/12/1993 | 43,98 | 45,85 | 43,04 | 45,85 | +3,16% | 6,38% | 1.095 |
| 10/12/1993 | 43,04 | 45,85 | 43,04 | 44,45 | -3,06% | 6,52% | 1.897 |